Safety, Efficacy, PK and PD of CTAP101 (Calcifediol) ER Capsules for SHPT in HD Patients VDI
Trial details
- Registry ID
- NCT03602261
- Phase
- Phase 2
Drug identity checked against registry records
Also recorded as CTAP101
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Safety, Efficacy, PK and PD of CTAP101 (Calcifediol) ER Capsules for SHPT in HD Patients VDINCT03602261 | OPK | Phase 2 | Terminated | 2021-02-24Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |